Liu Q, Ou Y, Liu T, He Y, Quan X, Ouyang R
Sci Rep. 2025; 15(1):3481.
PMID: 39875482
PMC: 11775174.
DOI: 10.1038/s41598-025-88034-z.
Wang Y, Song M, Chang W
Cell Surf. 2024; 12:100135.
PMID: 39687062
PMC: 11646788.
DOI: 10.1016/j.tcsw.2024.100135.
El-Karim D, El-Amrawi G, Salama A
Open Vet J. 2024; 14(1):25-31.
PMID: 38633174
PMC: 11018400.
DOI: 10.5455/OVJ.2024.v14.i1.4.
Dong Z, Liu Z, Xu Y, Tan B, Sun W, Ai Q
Front Immunol. 2024; 15:1354040.
PMID: 38529273
PMC: 10961442.
DOI: 10.3389/fimmu.2024.1354040.
Mourenza A, Ganesan R, Camarero J
RSC Chem Biol. 2023; 4(10):722-735.
PMID: 37799576
PMC: 10549238.
DOI: 10.1039/d3cb00015j.
Decreased salivary beta-defensin 2 in children with asthma after treatment with corticosteroid inhaler.
Moosavi M, Hosseinizade P, Panahi G, Shariat M
Eur Arch Paediatr Dent. 2023; 24(2):249-254.
PMID: 36749545
DOI: 10.1007/s40368-022-00776-w.
Human beta-defensin 1 circulating level and gene polymorphism in non-segmental vitiligo Egyptian patients.
Farag A, Shoeib M, Labeeb A, Sleem A, Khallaf H, Khalifa A
An Bras Dermatol. 2022; 98(2):181-188.
PMID: 36535830
PMC: 9984704.
DOI: 10.1016/j.abd.2022.04.002.
Defensins: defenders of human reproductive health.
Zhai Y, Feng Y, Ma X, Ma F
Hum Reprod Update. 2022; 29(1):126-154.
PMID: 36130055
PMC: 9825273.
DOI: 10.1093/humupd/dmac032.
Roles of Antimicrobial Peptides in Gynecological Cancers.
Zhao C, Yan S, Song Y, Xia X
Int J Mol Sci. 2022; 23(17).
PMID: 36077500
PMC: 9456504.
DOI: 10.3390/ijms231710104.
Surfactant proteins and innate immunity of otitis media.
Abdel-Razek O, Audlin J, Poe D, Wang G
Innate Immun. 2022; 28(7-8):213-223.
PMID: 36069032
PMC: 9900255.
DOI: 10.1177/17534259221123309.
Increased fecal human beta-defensin-2 expression in preterm infants is associated with allergic disease development in early childhood.
Hua M, Chen C, Liao S, Yao T, Tsai M, Lai S
World Allergy Organ J. 2022; 15(5):100633.
PMID: 35600835
PMC: 9109190.
DOI: 10.1016/j.waojou.2022.100633.
Identification of Novel Disease-Relevant Genes and Pathways in the Pathogenesis of Type 1 Diabetes: A Potential Defect in Pancreatic Iron Homeostasis.
Yip L, Alkhataybeh R, Taylor C, Fuhlbrigge R, Fathman C
Diabetes. 2022; 71(7):1490-1507.
PMID: 35499603
PMC: 9233262.
DOI: 10.2337/db21-0948.
Host Defence Peptides in Diabetes Mellitus Type 2 Patients with Periodontal Disease. A Systematic Review.
Shaikh M, Zafar M, Saleem F, Alnazzawi A, Lone M, Bukhari S
Diagnostics (Basel). 2021; 11(12).
PMID: 34943445
PMC: 8700015.
DOI: 10.3390/diagnostics11122210.
Innate Immunity in the Middle Ear Mucosa.
Massa H, Spann K, Cripps A
Front Cell Infect Microbiol. 2021; 11:764772.
PMID: 34778109
PMC: 8586084.
DOI: 10.3389/fcimb.2021.764772.
In vitro antiviral activity of peptide-rich extracts from seven Nigerian plants against three non-polio enterovirus species C serotypes.
Ogbole O, Akinleye T, Nkumah A, Awogun A, Attah A, Adewumi M
Virol J. 2021; 18(1):161.
PMID: 34348755
PMC: 8335448.
DOI: 10.1186/s12985-021-01628-7.
Human Beta-Defensin 2 and 3 Inhibit HIV-1 Replication in Macrophages.
Bharucha J, Sun L, Lu W, Gartner S, Garzino-Demo A
Front Cell Infect Microbiol. 2021; 11:535352.
PMID: 34277460
PMC: 8281893.
DOI: 10.3389/fcimb.2021.535352.
Murepavadin, a Small Molecule Host Defense Peptide Mimetic, Activates Mast Cells MRGPRX2 and MrgprB2.
Amponnawarat A, Chompunud Na Ayudhya C, Ali H
Front Immunol. 2021; 12():689410.
PMID: 34248979
PMC: 8261236.
DOI: 10.3389/fimmu.2021.689410.
Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.
Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E
Viruses. 2021; 13(7).
PMID: 34206990
PMC: 8310277.
DOI: 10.3390/v13071246.
Expression and Functional Characterization of a Novel Antimicrobial Peptide: Human Beta-Defensin 118.
Lin Q, Xie K, Chen D, Yu B, Mao X, Yu J
Biomed Res Int. 2020; 2020:1395304.
PMID: 33224970
PMC: 7673234.
DOI: 10.1155/2020/1395304.
Cooperative Function of LL-37 and HNP1 Protects Mammalian Cell Membranes from Lysis.
Drab E, Sugihara K
Biophys J. 2020; 119(12):2440-2450.
PMID: 33157121
PMC: 7822736.
DOI: 10.1016/j.bpj.2020.10.031.